How effective is Ursodiol for Biliary Cirrhosis Primary? (a real world drug study)
Summary:
Overall ratings: 3.6/5 Long term ratings: 3.9/5
This is a phase IV clinical study of how effective Ursodiol (ursodiol) is for Biliary cirrhosis primary and for what kind of people. The study is created by eHealthMe from 21 Ursodiol users and is updated continuously.
What is Ursodiol?
Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.
What is Biliary cirrhosis primary?
Biliary cirrhosis primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver) is found to be associated with 72 drugs and 253 conditions by eHealthMe. Check the latest studies of Biliary cirrhosis primary.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
21 people are studied for taking Ursodiol in Biliary cirrhosis primary
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Ursodiol effectiveness for Biliary cirrhosis primary (number of people):
Overall:
- not at all: 1
- somewhat: 3
- moderate: 5
- high: 7
- very high: 5
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 4
- high: 4
- very high: 5
Gender of people who take Ursodiol for Biliary cirrhosis primary *:
- female: 95.24 %
- male: 4.76 %
Age of people who take Ursodiol for Biliary cirrhosis primary *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.52 %
- 40-49: 9.52 %
- 50-59: 33.33 %
- 60+: 47.62 %
Who find Ursodiol more effective for Biliary Cirrhosis Primary?
Gender of people who take Ursodiol for Biliary cirrhosis primary *:
- female: 91.67 %
- male: 8.33 %
Age of people who take Ursodiol for Biliary cirrhosis primary *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 33.33 %
- 60+: 66.67 %
* Approximation only. Some reports may have incomplete information.
Do you take Ursodiol?
- You can start a phase IV clinical trial to monitor Ursodiol safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Ursodiol (19,061 reports)
Treatments, associated drugs and conditions:
- Biliary cirrhosis primary (2,093 reports)
How the study uses the data?
The study is based on ursodiol (the active ingredients of Ursodiol) and Ursodiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hydrea cause Chills? - a second ago
- Could Crestor cause Muscle Enzyme Increased? - 3 seconds ago
- Could Imfinzi cause Hypotension? - 4 seconds ago
- Could Hydramine cause Uterine Infection? - 4 seconds ago
- Drug interactions of Sulindac and Effexor - 4 seconds ago
- Could Mycophenolate Mofetil cause Electrocardiogram St Segment Elevation? - 9 seconds ago
- Could Xofigo cause Febrile Neutropenia? - 9 seconds ago
- Could Nexium cause Live Birth? - 16 seconds ago
- Drug interactions of Prozac and Azithromycin - 20 seconds ago
- Drug interactions of Esomeprazole Sodium and Allopurinol - 22 seconds ago